Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2004
08/05/2004US20040152677 (20S)-1alpha-hydroxy-2alpha-methl and 2beta-methyl-19-nor-vitamin D3 and their uses
08/05/2004US20040152676 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
08/05/2004US20040152675 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
08/05/2004US20040152626 Identification of novel splice variants of the human catalytic subunit cbeta of camp-dependent protein kinase and the use thereof
08/05/2004US20040152191 Using activator glycoprotein to propagate activated macrophages or dendritic cells from monocytes or hematopoietic stem cells for use in treatment of allergic, cell proliferative, autoimmune and infectious disorders
08/05/2004US20040152157 G-protein coupled receptors
08/05/2004US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease
08/05/2004US20040152078 Genetic engineering
08/05/2004US20040151938 Supplying to human or animals; into brain, tissues, lungs; coils, spring
08/05/2004US20040151733 at least two conjugated antigens that are glycolipid antigen, polysaccharide antigen, mucin antigen, and/or glycosylated mucin antigen and an adjuvant; especially for treating small cell lung cancer
08/05/2004US20040151726 Novel vaccine for prophylaxis and theraphy in vetirinary and human medicine
08/05/2004US20040151723 specific to cancerous and precancerous lesions of the uterus
08/05/2004US20040151720 Cell surface molecule mediating cell adhesion and signal transmission
08/05/2004US20040151717 Use of polyclonal immunoglobulins
08/05/2004US20040151669 Lymph cells detected by monoclonal antibodies; diagnosis of autoimmune disease, antiallergens
08/05/2004CA2514108A1 Drugs containing galectin 9
08/05/2004CA2513320A1 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
08/05/2004CA2512709A1 Use of tff2, or agents inducing tff2, in the therapy of allergies
08/05/2004CA2512136A1 Thienopyridazinones and their use in modulation of autoimmune disease
08/04/2004EP1443108A2 Processes for preparing reconstructed skin supplemented in ceramid 7 and/or 5.5, composition based on lamellar lipid vesicles comprising a derivative of ceramid 7 and/or 5.5 and use thereof
08/04/2004EP1442749A1 Use of anti-CD100 antibodies for the treatment and the diagnosis of inflammatory disorder affecting the central nervous system
08/04/2004EP1442143A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/04/2004EP1442064A2 Kinases and phosphatases
08/04/2004EP1442061A1 Reducing immunogenicities of immunoglobulins by framework-patching
08/04/2004EP1442058A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/04/2004EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
08/04/2004EP1442049A2 Substituted amino ketone compounds
08/04/2004EP1442047A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/04/2004EP1442046A2 Mammalian c-type lectins
08/04/2004EP1442042A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
08/04/2004EP1442039A1 Pyrimido (4,5-b) indole derivatives
08/04/2004EP1442036A2 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1
08/04/2004EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
08/04/2004EP1442026A1 Triazole derivatives as cyclooxygenase (cox) inhibitors
08/04/2004EP1442017A1 Preparation of benzosuberonylpiperidine compounds
08/04/2004EP1442008A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists
08/04/2004EP1441772A2 Polymer conjugates of protein kinase c inhibitors
08/04/2004EP1441771A1 Aqueous sustained-release formulations of proteins
08/04/2004EP1441763A2 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
08/04/2004EP1441762A1 Rsv gene expression vaccine
08/04/2004EP1441738A1 A combination product comprising melagatran and dexamethasone
08/04/2004EP1441732A2 Thiazole derivative and pharmaceutical use thereof
08/04/2004EP1441730A1 Hydrazono-malonitriles
08/04/2004EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
08/04/2004EP1441718A2 Carbinols for the treatment of neuropathic dysfunction
08/04/2004EP1441716A1 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions
08/04/2004EP1441715A1 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
08/04/2004EP1441701A1 Montelukast granule formulation
08/04/2004EP1441656A1 Method and apparatus for production of a skin graft and the graft produced thereby
08/04/2004EP1441591A2 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
08/04/2004EP1441589A2 Stable liquid pharmaceutical formulation of igg antibodies
08/04/2004EP1289945B1 Aniline disulfide derivatives for treating allergic diseases
08/04/2004EP1280806B1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS
08/04/2004EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
08/04/2004EP1150658B1 Method for controlling liposome size
08/04/2004EP1127071B1 Compounds with growth hormone releasing properties
08/04/2004EP1124829B1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
08/04/2004EP1112262B1 Substituted gamma-phenyl-delta-lactones and analogs thereof and uses related thereto
08/04/2004EP1034001B1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome
08/04/2004EP0912571B1 Naphthyridines which affect il-4 and g-csf
08/04/2004EP0764171B1 Ligands for induction of antigen specific apoptosis in t cells
08/04/2004EP0637963B1 Cd28 pathway immunoregulation
08/04/2004CN1518598A Serpin in Bifidobacteria
08/04/2004CN1518559A VHH single heavy chain antibody and method for its preparation in mammal
08/04/2004CN1518558A Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament
08/04/2004CN1518552A Pyrrolopyrimidines as protein kinase inhitibors
08/04/2004CN1518551A Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient
08/04/2004CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
08/04/2004CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3
08/04/2004CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors
08/04/2004CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
08/04/2004CN1518459A Remedies for eosinophilic diseases
08/04/2004CN1518458A Graft rejection inhibitors
08/04/2004CN1518448A Antihistamines for treatment of nasal congestion and nasal obstruction
08/04/2004CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
08/04/2004CN1518442A Pharmaceutical compositions comprising cyclosporin
08/04/2004CN1160457C Recombinant mistletoe lectin (rML)
08/04/2004CN1160371C NOTCH protein and their ligands
08/04/2004CN1160359C Dithiepino [6,5-b] pyridines, and related compsns. and methods for preparing and use
08/04/2004CN1160357C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid
08/04/2004CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use
08/04/2004CN1160343C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells
08/04/2004CN1160116C Specific immunological inhibitor
08/04/2004CN1160075C Use of heterocyclic amide compound for preparing IgE antibody production inhibitors
08/04/2004CN1159984C Prophylactic dietary supplement based on milk
08/03/2004US6770778 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
08/03/2004US6770656 Amine derivatives for the treatment of apoptosis
08/03/2004US6770654 Indole derivatives and use thereof in medicines
08/03/2004US6770647 Osteoporosis; rheumatic diseases
08/03/2004US6770646 Substituted fused pyridazinone compounds; composition and use thereof
08/03/2004US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient
08/03/2004US6770643 Inhibit protein kinases
08/03/2004US6770637 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors
08/03/2004US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors
08/03/2004US6770620 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
08/03/2004US6770466 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders
08/03/2004US6770281 B-cell epitope peptides of HSP 65
08/03/2004US6770267 Methods of treating periodontal disease
08/03/2004US6770260 Mammal model contains a decreased level of endogenous macrophages sufficient to reduce depletion of non-autologous hematopoietic cells, achieved by administering an effective amount of dichloromethylene diphosphonate
07/2004
07/29/2004WO2004063363A1 Different dendritic cell subsets